Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Neurogastroenterol Motil. 2023 Dec 28;36(3):e14732. doi: 10.1111/nmo.14732

Table 2.

Contractile activity after treatment and relationship with HRM and FLIP EGJ opening parameters in the entire cohort, in the subgroup with ‘normal EGJ’ metrics and with ‘abnormal EGJ’ metrics (IRP <15 mmHg and normal EGJ opening classification on FLIP).

Entire cohort Normal EGJ subgroup Abnormal EGJ subgroup
No contractility Contractility present No contractility Contractility present No contractility Contractility present
N 61 61 20 33 41 28
Post-treatment HRM
IRP, mmHg, median (IQR) 13 (10–20) 12 (9–16) 11 (8–13) 10 (7–14) 17 (11–21) 17 (12–21)
DCI, mmHg∙s∙cm, median (IQR) 0 (0–0) 297 (183–545) 0 (0–0) 278 (180–471) 0 (0–0) 415 (196–697)
% swallows with DCI > 100, median (IQR) 0 (0–0) 80 (50–100) - - - -
Contractility pattern, n (%)
Normal 0 5 (8) 0 4 (6) 0 5 (18)
Ineffective 0 42 (69) 0 20 (67) 0 18 (64)
Absent 61 (100) 0 20 (100) 0 41 (100) 0
Premature 0 14 (23) 0 9 (27) 0 5 (18)
Post-treatment FLIP
60ml pressure, mmHg, median (IQR) 25 (21–31) 29 (24–33) 23 (20–28) 29 (25–32) 26 (21–33) 29 (24–36)
Max EGJ diameter, mm, median (IQR) 16 (13–18) 17 (16–19) 17 (17–19) 18 (17–20) 14 (13–16) 16 (14–18)
EGJ-DI, mm2/mmHg, median (IQR) 4.3 (2.6–6.6) 5.0 (3.5–6.1) 6.6 (4.5–7.1) 5.8 (4.8–6.8) 3.3 (2.3–4.7) 3.5 (2.4–5.0)
Contractile response pattern, n (%)
Normal 0 0 0 0 0 0
Borderline 0 3 (5) 0 1 (3) 0 2 (7)
Impaired-disordered 36 (59) 43 (70) 13 (65) 26 (79) 24 (59) 17 (61)
Absent 23 (38) 10 (16) 7 (35) 5 (15) 16 (39) 5 (18)
Spastic-reactive 1 (2) 5 (8) 0 1 (3) 1 (2) 4 (14)
EGJ opening classification, n (%)
Normal 30 (49) 42 (69) 20 (100) 33 (100) 10 (24) 9 (32)
Borderline-normal 10 (16) 14 (23) - - 10 (24) 14 (50)
Borderline-reduced 14 (23) 4 (7) - - 14 (35) 4 (14)
Reduced 7 (12) 1 (2) - - 7 (17) 1 (4)
Normal + Borderline-normal 40 (66) 56 (92) - - 20 (40) 25 (89)
Reduced + Borderline-reduced 21 (34) 5 (8) - - 21 (42) 5 (18)
Post-treatment TBE
1-minute column height, cm, median (IQR) 8 (5–12) 4 (0–8) 7 (5–10) 4 (0–7) 8 (5–13) 5 (0–12)
5-minute column height, cm, median (IQR) 6 (2–9) 0 (0–4) 5 (2–7) 0 (0–3) 7 (2–11) 0 (0–7)
5-minute column height <5cm, n (%) 25 (40) 48 (78) 10 (50) 28 (88) 15 (37) 20 (71)
Esophageal width, cm (IQR) 2.9 (2.0–3.5) 2.1 (1.7–2.7) 2.6 (1.6–3.1) 1.8 (1.7–2.3) 3.2 (2.3–3.9) 2.3 (1.8–3.0)
Symptoms n=52 n=55 n=16 n=30 n=36 n=25
Eckardt score, median (IQR) 3 (1–4) 2 (1–3) 2 (1–4) 2 (1–4) 3 (2–4) 2 (1–3)
Eckardt score ≤3, n (%) 33 (63) 43 (78) 11 (68) 22 (73) 22 (61) 21 (84)

Comparisons with significant (p<0.05) differences are marked in bold.

IRP: integrated relaxation pressure, EGJ: esophagogastric junction; EGJ-DI: esophagogastric junction distensibility index, TBE: timed barium esophagram, HRM: high-resolution-manometry, DCI: distal contractile integral, FLIP: functional luminal imaging probe.